Module 1B rational dosage form design Flashcards
What are the bio pharmaceutical considerations in the design and manufacture of drugs (6)
- Aqueous solubility
- Lipid-aqueous partition coefficient
- Absorption across membranes
- Protection from acidic environment
- Metabolic inactivation
- Prodrugs
Outline the physiochemical and bio pharmaceutical properties of a drug that are considered when developing a suitable dosage form (5)
- pH solubility and dissolution rate
- Partition coefficient
- Stability or degradation rate in the body
- Susceptibility to metabolic inactivation
- Mechanism of transport through membranes
Importance of polymorphism in drug dosage form design (4)
Polymorphism is the ability of a chemical species to crystallise into more than 1 crystal habit
This causes different:
-dissolution rates and solubility
Having a dramatic impact on bioavailability when dissolution is the rate limiting step in absorption
When is controlling the release of drug desirable (2)
When compounds are:
- absorbed rapidly through mucous membranes or
- removed rapidly from the site of action
The approach normally reduces the systemic side effects of the drug
Describe the primary advantages of delivering drugs via alternative routes vs oral route (3)
- Avoids absorption and metabolic barriers in GI tract
- Provides systemic availability when oral admin is contraindicated
- Provide a concentration-time profile similar to IV dosing
Describe the rate limiting steps in oral drug absorption (3)
- Disintegration
- Dissolution
- Absorption
Define biopharmaceuticals (2)
Allows for rational design of drug products
-delivers the drug at a specific rate to optimise thereputic effect and minimise adverse effects
Define drug delivery system
System of delivering drugs to the target site
- drug product
- drug dosage form
Define bio equivalent drug product
Pharmaceutical equivalents whose bioavailability does not show a significant difference
Define generic drug product
Bio equivalent as well as the rate and extent of systemic drug absorption is not statistically different under:
- the same experimental conditions - route of administration - similar dosage form - same chemical form - same dose